CareSuper and Spirit Super have confirmed they are on track to deliver on their merger later this year.
The merger is expected to take effect from 1 November and the newly formed entity will be called CareSuper.
Explaining the name change, current CareSuper chair Linda Scott said: “While this is a true merger of equals, both funds decided it was in the best interests of members to call the fund CareSuper to take advantage of strong recognition for the name, which has been in the market since 1986.
“Elements of the Spirit Super brand identity will be retained to highlight our shared national heritage and member focus, including Spirit Super’s distinctive logo which enjoys strong and positive recognition among its membership.”
The funds first announced they were exploring a potential merger in November 2022 and subsequently entered into a memorandum of understanding.
Following an extensive due diligence process, Spirit Super and CareSuper entered into a binding agreement to merge in June 2023.
At the time, they flagged the merger was expected to be completed in late 2024, with the combined entity to be chaired by Scott.
Jason Murray, CEO of Spirit Super since February 2022, would become the CEO of the combined fund.
From 1 November 2024, the rest of the designated executive team will comprise:
Commenting on the merger update, Spirit Super CEO Murray confirmed members and stakeholders “will be kept informed as the merger progresses”.
“We’re moving forward confidently to deliver even greater products, services and experiences for our collective membership,” Murray said.
Jim Chalmers has defended changes to the Future Fund’s mandate, referring to himself as a “big supporter” of the sovereign wealth fund, amid fierce opposition from the Coalition, which has pledged to reverse any changes if it wins next year’s election.
In a new review of the country’s largest fund, a research house says it’s well placed to deliver attractive returns despite challenges.
Chant West analysis suggests super could be well placed to deliver a double-digit result by the end of the calendar year.
Specific valuation decisions made by the $88 billion fund at the beginning of the pandemic were “not adequate for the deteriorating market conditions”, according to the prudential regulator.